ALZN vs. SAVA

In the year-to-date period, ALZN achieves a -42.93% return, which is significantly lower than SAVA's -32.63% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Alzamend Neuro, Inc. (ALZN) and Cassava Sciences, Inc. (SAVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ALZN Sharpe Ratio is -0.43, which is higher than the SAVA Sharpe Ratio of -0.64. The chart below compares the historical Sharpe Ratios of ALZN and SAVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ALZN nor SAVA has paid dividends to shareholders.

The maximum ALZN drawdown since its inception was -99.97%, roughly equal to the maximum SAVA drawdown of -99.18%. Use the drawdown chart below to compare losses from any high point for ALZN and SAVA. For additional features, visit the drawdowns tool.

The current volatility for Alzamend Neuro, Inc. (ALZN) is 19.96%, while Cassava Sciences, Inc. (SAVA) has a volatility of 25.54%. This indicates that ALZN experiences smaller price fluctuations and is considered to be less risky than SAVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Alzamend Neuro, Inc. and Cassava Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.